Response to the letter to the editor-'Amiodarone-induced phlebitis: incidence and adherence to a clinical practice guideline' by Jafari et al.

被引:0
|
作者
Brors, Gunhild [1 ]
Gjeilo, Kari Hanne [1 ,2 ]
Mjolstad, Ole Christian [1 ,3 ]
机构
[1] Trondheim Reg & Univ Hosp, St Olavs Hosp, Clin Cardiol, Prinsesse Kristinas gate 3, N-7030 Trondheim, Norway
[2] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Trondheim, Norway
[3] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway
关键词
D O I
10.1093/eurjcn/zvad058
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E135 / E136
页数:2
相关论文
共 50 条
  • [1] Letter to the editor: 'Amiodarone-induced phlebitis: incidence and adherence to a clinical practice guideline'
    Jafari, Hedayat
    Shafipour, Vida
    Kamali, Mahsa
    Mollaei, Amirabbas
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2023, 22 (08) : E133 - E134
  • [2] Amiodarone-induced phlebitis: incidence and adherence to a clinical practice guideline
    Brors, Gunhild
    Gjeilo, Kari Hanne
    Lund, Tonje
    Skevik, Karin
    Aa, Elizabeth
    Hovik, Lise Husby
    Skarsvaag, Torhild
    Mjolstad, Ole Christian
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2023, 22 (08) : 824 - 831
  • [3] Response to Letter to the Editor from Sukor et al.: "Evaluation and Treatment of Amiodarone-induced Thyroid Disorders"
    Ylli, Dorina
    Wartofsky, Leonard
    Burman, Kenneth D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (07) : E2839 - E2840
  • [4] Letter to the Editor: Comment on Pagets Disease Clinical Practice Guideline by Singer et al Response
    Singer, Frederick R.
    Bone, Henry G., III
    Hoskings, David J.
    Lyles, Kenneth W.
    Reid, Ian R.
    Siris, Ethel S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (05)
  • [5] Letter to the Editor from Sukor et al: "Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders"
    Sukor, Norlela
    Lachumanan, Deviga
    Kamaruddin, Nor Azmi
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (06) : E2457 - E2458
  • [6] Authors Reply to Letter to the Editor- In Response to: Comment on Durrani et al.'s "Adalimumab for Ocular Inflammation"
    Durrani, Khayyam
    Kempen, John H.
    Foster, C. Stephen
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (01) : 71 - 71
  • [7] Letter to the editor in response to Tang et al.
    Brown, Austin L.
    Abu-Arja, Mohammad H.
    Chintagumpala, Murali M.
    Paulino, Arnold C.
    NEURO-ONCOLOGY, 2024,
  • [8] Response to the letter to the editor of Lambros et al.
    William Sterlacci
    Alexandar Tzankov
    Spasenija Savic
    Virchows Archiv, 2017, 471 (5) : 687 - 688
  • [9] Response to the Letter to the Editor by Bett et al.
    Almandoz, Jaime P.
    Wadden, Thomas A.
    Tewksbury, Colleen
    Apovian, Caroline M.
    Fitch, Angela
    Ard, Jamy D.
    Li, Zhaoping
    Richards, Jesse
    Butsch, W. Scott
    Jouravskaya, Irina
    Vanderman, Kadie S.
    Neff, Lisa M.
    OBESITY, 2024, 32 (11) : 1982 - 1984
  • [10] Response to Letter to the Editor by Kim et al.
    Claudia Papi
    Raffaele Iorio
    Neurological Sciences, 2023, 44 : 4535 - 4535